论文部分内容阅读
据新近在德国召开的第九次欧洲临床微生物学与传染病学学术会议报道，Pharmacia＆Upjohn公司的唑烷酮类抗菌药物Linezolid（商品名Zyvox）能有效抗革兰阳性菌。在一项Ⅱ期临床研究中，273例并发或本并发皮肤，软组织感染的住院病人，静往低剂量本品250mg-日3次或375mg—日2次（
According to a recent report in the 9th European Conference on Clinical Microbiology and Infectious Diseases held in Germany, Pharmazos and Upjohn’s azazolidinone linezolid (Zyvox) is effective against Gram-positive bacteria. In a Phase II clinical study, 273 inpatients with concomitant or concurrent skin and soft tissue infections were intravenously given a low dose of this product 250 mg-day 3 or 375 mg-day 2 (